Tenon Medical, Inc. Operating Lease, Payments
Tenon Medical, Inc. (TNON) reported Operating Lease, Payments of $268.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-13
- Tenon Medical, Inc. operating lease, payments for the quarter ending 2026-06-30 was $189.00K, a 145.45% increase year-over-year.
- Tenon Medical, Inc. operating lease, payments for the quarter ending 2026-03-31 was $79.00K, a 3.95% increase year-over-year.
- Tenon Medical, Inc. operating lease, payments for the quarter ending 2025-12-31 was $78.00K, a 2.63% increase year-over-year.
- Tenon Medical, Inc. operating lease, payments for the quarter ending 2025-09-30 was $79.00K, a 2.60% increase year-over-year.
- Tenon Medical, Inc. operating lease, payments for fiscal 2025 was $310.00K, a 2.99% increase from fiscal 2024.
- Tenon Medical, Inc. operating lease, payments for fiscal 2024 was $301.00K, a 2.73% increase from fiscal 2023.
- Tenon Medical, Inc. operating lease, payments for fiscal 2023 was $293.00K, a 3.17% increase from fiscal 2022.
- Tenon Medical, Inc. operating lease, payments for fiscal 2022 was $284.00K, a 121.88% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $189.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $268.00K 10-Q · filed 2026-08-13 | $346.00K derived: sum of 3 quarters · filed 2026-08-13 | $425.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $79.00K 10-Q · filed 2026-05-15 | $157.00K derived: sum of 2 quarters · filed 2026-05-15 | $236.00K derived: sum of 3 quarters · filed 2026-05-15 | $313.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $157.00K derived: sum of 2 quarters · filed 2026-03-27 | $234.00K derived: sum of 3 quarters · filed 2026-08-13 | $310.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $156.00K derived: sum of 2 quarters · filed 2026-08-13 | $232.00K 10-Q · filed 2025-11-13 | $308.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $153.00K 10-Q · filed 2026-08-13 | $229.00K derived: sum of 3 quarters · filed 2026-08-13 | $306.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $76.00K 10-Q · filed 2026-05-15 | $152.00K derived: sum of 2 quarters · filed 2026-05-15 | $229.00K derived: sum of 3 quarters · filed 2026-05-15 | $303.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $153.00K derived: sum of 2 quarters · filed 2026-03-27 | $227.00K derived: sum of 3 quarters · filed 2026-03-27 | $301.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $151.00K derived: sum of 2 quarters · filed 2025-11-13 | $225.00K 10-Q · filed 2025-11-13 | $300.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $148.00K 10-Q · filed 2025-08-13 | $223.00K derived: sum of 3 quarters · filed 2025-08-13 | $297.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $74.00K 10-Q · filed 2025-05-13 | $149.00K derived: sum of 2 quarters · filed 2025-05-13 | $223.00K derived: sum of 3 quarters · filed 2025-05-13 | $295.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $149.00K derived: sum of 2 quarters · filed 2025-03-26 | $221.00K derived: sum of 3 quarters · filed 2025-03-26 | $293.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $146.00K derived: sum of 2 quarters · filed 2024-11-14 | $218.00K 10-Q · filed 2024-11-14 | $290.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $144.00K 10-Q · filed 2024-08-13 | $216.00K derived: sum of 3 quarters · filed 2024-08-13 | $288.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $72.00K 10-Q · filed 2024-05-15 | $144.00K derived: sum of 2 quarters · filed 2024-05-15 | $216.00K derived: sum of 3 quarters · filed 2024-05-15 | $286.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $144.00K derived: sum of 2 quarters · filed 2024-03-29 | $214.00K derived: sum of 3 quarters · filed 2024-03-29 | $284.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $142.00K derived: sum of 2 quarters · filed 2023-11-14 | $212.00K 10-Q · filed 2023-11-14 | $282.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $140.00K 10-Q · filed 2023-08-11 | $210.00K derived: sum of 3 quarters · filed 2023-08-11 | $245.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $70.00K 10-Q · filed 2023-05-09 | $140.00K derived: sum of 2 quarters · filed 2023-05-09 | $175.00K derived: sum of 3 quarters · filed 2023-05-09 | |
| 2021-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $105.00K derived: sum of 2 quarters · filed 2023-03-10 | $128.00K 10-K · filed 2023-03-10 | |
| 2021-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $58.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $23.00K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |